Oral Nalbuphine May Improve Itch and Lesions in Patients With Prurigo Nodularis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the European Academy of Dermatology and Venereology: JEADV
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a phase 2 randomized controlled trial with an open-label extension phase
J Eur Acad Dermatol Venereol 2021 Nov 15;[EPub Ahead of Print], E Weisshaar, JC Szepietowski, JD Bernhard, H Hait, FJ Legat, L Nattkemper, A Reich, B Sadoghi, TR Sciascia, C Zeidler, G Yosipovitch, S StänderFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.